Navigation Links
American Brain Tumor Association and Cleveland Clinic Conference Offers Continuing Education to Health Care Professionals

Chicago, IL (PRWEB) September 24, 2013

The American Brain Tumor Association (ABTA), in joint sponsorship with Cleveland Clinic, will present the 15th Annual Brain Tumor Update and 4th Annual International Symposium on Long-term Control of Metastases to the Brain and Spine on Saturday, Nov. 9 and Sunday, Nov. 10 at the Bellagio Hotel in Las Vegas.

The first day of the conference will feature a new “Partners in Care” track developed by the ABTA specifically for nurses, social workers and physicians seeking to advance their knowledge of issues that directly impact brain tumor patients and their families. The track will address the care of patients with either metastatic or primary brain tumors.

Recently, the ABTA conducted an extensive survey of health care professionals from across the United States, the results of which informed the development of the “Partners in Care” conference track.

“Professional development is an important part of helping to move the brain tumor field forward, and health care professionals turn to the ABTA as a trusted resource,” says Mary Lovely, PhD, ABTA senior advisor, Mission Division, and course co-director. “Our recent needs assessment showed that the vast majority of health care professionals seek information about brain tumors, not only to assist patients, but also to increase their personal knowledge. And by far, their most preferred method of learning is the professional conference setting. In partnering with Cleveland Clinic, the ABTA can provide an important, sought-after educational opportunity to health care professionals who are interacting with patients and families every day.”

The “Partners in Care” session will identify specific, practical strategies for living with a brain tumor including symptom management, caregiver needs, palliative care and the financial aspects of brain tumor care. Nationally recognized experts will provide overviews of cerebral functions affected by brain tumors, common tumor types and treatments, assessing cognition changes, the management of fatigue and financial resources.

The second day of the conference will offer all attendees an opportunity to learn about updates in management of unusual tumors, advancements in the treatment of gliomas, new surgical techniques and more.

Individuals can choose to attend one or both days. For the full conference program and registration information, visit

This activity has been approved for AMA PRA Category 1 Credits™. Continuing Education Units are available for nurses. This activity is pending approval from the National Association of Social Workers.


Founded in 1973, the American Brain Tumor Association was the first and is now the only national organization committed to funding brain tumor research and providing support and education programs for all tumor types and all age groups. For more information, visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Clinical news alert from the American Academy of Orthopaedic Surgeons
2. American College of Cardiology cites new USF Simulation Center for Training Excellence
3. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
4. Young Americans Need to Cut Calorie Intake: Study
5. Hutchinson Center president elected to American Academy of Art and Sciences
6. Can weight loss help African-American breast cancer survivors?
7. Americans Support Medicare Reform, But Not on Their Dime: Poll
8. One-third of adult Americans with arthritis battle anxiety or depression
9. Equal access to care helps close survival gap for young African-American cancer patients
10. Systemic sclerosis complications more severe in African Americans than Caucasians
11. 53 million Americans might have diabetes by 2025, according to a new study in Population Health Management
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Brenntag ... exclusive channel partner for the Nutraceutical Specialties products into oral solid dosage in ... immediately. , “We are pleased to announce our expanded distribution agreement with ...
(Date:11/30/2015)... , ... November 30, 2015 , ... An inventor from ... in the womb. "My last baby had high blood pressure due to loud noises," ... to protect their babies from noise pollution as well as radio waves and microwaves." ...
(Date:11/30/2015)... ... November 30, 2015 , ... Since its inception, ... in independent living, assisted living and all other retirement options. Support for issues ... and research remains a top priority. , So it’s no surprise that ...
(Date:11/30/2015)... ... 30, 2015 , ... Sikka Software announced today that they are showcasing the ... to make complex business decisions by providing the tools and information they need to ... with 10 procedures customized by zip code. , The Sikka Software Ecosystem includes ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... the assets of DataTrade Solutions Inc., a Healthcare IT consulting, development and support ... the programming and technical experience available within DataTrade to extend the services currently ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... NEW YORK , November 27, 2015 ... health system is set to go online. The potential ... and processes is vast and far from fully exploited ... access to patient health records, either via mobile tablet ... ) --> ) ...
(Date:11/27/2015)... PHILADELPHIA , Nov. 27, 2015  Lannett ... that it has completed the acquisition of Kremers ... pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A. ... --> Lannett has acquired KU from UCB ... to certain adjustments, including a customary working capital ...
(Date:11/27/2015)... 2015 ... "2016 Global Tumor Marker Testing Market: ... Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, ... their offering. --> ) ... "2016 Global Tumor Marker Testing Market: Supplier ...
Breaking Medicine Technology: